ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

EYLEA
Miscellaneous ocular agents
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

EYLEA Rx

Generic Name and Formulations:
Aflibercept 40mg/mL; soln for oph intravitreal inj; preservative-free.

Company:
Regeneron

Therapeutic Use:

Indications for EYLEA:

Neovascular (wet) age-related macular degeneration (AMD). Macular edema following retinal vein occlusion (RVO). Diabetic macular edema (DME).

Adult:

Give by intravitreal injection. AMD: 2mg (0.05mL) once every 4 weeks (monthly) for the 1st 3 months, followed by 2mg (0.05mL) once every 8 weeks. RVO: 2mg (0.05mL) once every 4 weeks (monthly). DME: 2mg (0.05mL) once every 4 weeks (monthly) for the 1st 5 injections, followed by 2mg (0.05mL) once every 8 weeks (2 months).

Children:

Not established.

Pharmacological Class:

Recombinant fusion protein (human VEGF inhibitor + human IgG1).

Contraindications:

Ocular or periocular infections. Active intraocular inflammation.

Warnings/Precautions:

Potential risk of arterial thromboembolic events (eg, nonfatal stroke or MI, vascular death). Monitor for endophthalmitis and retinal detachments during the week following injection. Monitor intraocular pressure and perfusion of optic nerve head after injection. Pregnancy (Cat.C). Nursing mothers: not recommended.

Adverse Reactions:

Conjunctival hemorrhage, eye pain, cataract, vitreous detachment, vitreous floaters, increased intraocular pressure, conjunctival hyperemia, corneal erosion, inj site pain, foreign body sensation in eye.

How Supplied:

Vial (for single eye use)—1 (w. needles + syringe)

EYLEA

  • 0.05ml of 2mg/0.05ml vials (Qty:1)
  • appx. price $1896.00
GoodRx

Sign Up for Free e-newsletters